Isometric Versus Isotonic Exercise for Greater Trochanteric Pain Syndrome

July 18, 2018 updated by: NHS Greater Glasgow and Clyde

Isometric Versus Isotonic Exercise for Greater Trochanteric Pain Syndrome - a Randomised Controlled Trial Comparing Two Rehabilitation Programmes

This pilot randomised controlled trial will directly compare the effect of isometric exercise to isotonic exercise over a period of 12 weeks for participants with a clinical diagnosis of Greater Trochanteric Pain Syndrome (GTPS).

Study Overview

Detailed Description

Pain at the side of the hip over or around the greater trochanter of the femur has previously been termed as Greater Trochanteric Pain Syndrome (GTPS). Recent research has found that it is normally due to the gluteal tendons being torn or injured and is often termed as 'gluteal tendinopathy'. GTPS predominantly affects adults aged 40-60 years and is the second most common condition affecting the hip region after osteoarthritis. Quality of life scores are similar to those with advanced hip osteoarthritis but despite its prevalence and disease burden the most effective treatment for this problem is currently unknown.

Numerous studies have shown that exercise programmes are the most effective treatment for other lower limb tendon problems, particularly the Achilles and patella. These programmes typically last a minimum of 12 weeks and are often prescribed by physiotherapists as first-line treatment. However, there is currently limited evidence to support exercise for gluteal tendinopathy. The study plans to directly compare two different types of exercise programmes for those with GTPS for a period of 12 weeks. One group will receive an isometric exercise programme (where the muscle length does not change) and a second group an isotonic exercise programme (where the muscle length does change).

The primary outcome measure which will be used has recently been validated for patients with gluteal tendinopathy and measures function and disability. Additional secondary outcome measures will evaluate aspects relating to quality of life, physical activity and pain. Both groups will be compared at the start of the study and at different times up to a maximum of 12 weeks to help determine if one exercise programme is better than the other.

The results of this pilot study will also help to identify whether a larger trial would be possible in the future.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Glasgow, United Kingdom
        • NHS Greater Glasgow and Clyde

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Able to give written informed consent
  • Lateral hip pain for greater than 3 months
  • Pain on direct palpation of the gluteal tendon insertion on the greater trochanter and additionally at least one of the following pain provocation tests must also be positive:

    1. FABER (Flexion, Abduction, External Rotation of the hip)
    2. FADER (Flexion, Adduction, External Rotation of the hip)
    3. FADER and resisted Internal Rotation (IR) (FADER position plus resisted IR of the hip)
    4. Single leg stand for 30 seconds
    5. Resisted hip abduction at end-range adduction

Exclusion Criteria:

  • Physiotherapy for lateral hip pain in the past 6 months
  • Corticosteroid injection for lateral hip pain in past 3 months
  • Inability to actively abduct hip in side-lying
  • Pain reproduced with FADIR (Flexion, Adduction, Internal Rotation of hip) with concurrent hip osteoarthritis on anteroposterior (AP) pelvis x-ray defined as Kellgren-Lawrence > Grade 2 (mild)
  • Previous hip or lumbar spine surgery in past 12 months
  • Inflammatory joint disease
  • Unstable diabetes or cardiovascular disease
  • Known neurological disorders
  • Widespread chronic pain or fibromyalgia
  • Avascular necrosis
  • Pregnancy
  • Participants unable or unwilling to give informed consent
  • Participants who are unable to write, read or comprehend English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Isometric exercise
12 week Isometric exercise programme - two exercises (one side-lying and the other standing); six repetitions of each with muscle contraction sustained for 30 seconds. Exercises performed once daily with each session lasting no longer than 10 minutes.
Exercise programme where the muscle length and joint angle do not change due to the limb being held in a static position
Experimental: Isotonic exercise
12 week Isotonic exercise programme - two exercises (one side-lying and the other standing); each exercise - 3 sets of 10 repetitions, each repetition 6 seconds duration. Exercises performed once daily with each session lasting no longer than 10 minutes.
Exercise programme where both the muscle length and joint angle do change, consisting of concentric muscle actions (where the muscle shortens) and eccentric muscle actions (where the muscle lengthens)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure of disability
Time Frame: Baseline, 4 weeks and 12 weeks
Change in score on Victorian Institute of Sport Assessment-Gluteal (VISA-G) questionnaire
Baseline, 4 weeks and 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life
Time Frame: Baseline, 4 weeks and 12 weeks
Change in score on European Quality of Life (EQ-5D-5L) questionnaire
Baseline, 4 weeks and 12 weeks
Perceived change in hip pain
Time Frame: Baseline, 4 weeks and 12 weeks
Change in score on Global Rating of Change (GROC) Scale
Baseline, 4 weeks and 12 weeks
Pain intensity
Time Frame: Baseline, 4 weeks and 12 weeks
Change in score on Numeric Pain Rating Scale (NPRS)
Baseline, 4 weeks and 12 weeks
Pain catastrophisation
Time Frame: Baseline, 4 weeks and 12 weeks
Change in score on Pain Catastrophising Scale
Baseline, 4 weeks and 12 weeks
Hip disability
Time Frame: Baseline, 4 weeks and 12 weeks
Change in score on Hip Disability and Osteoarthritis Outcome Score (HOOS)
Baseline, 4 weeks and 12 weeks
Physical activity
Time Frame: Baseline, 4 weeks and 12 weeks
Change in score on International Physical Activity Questionnaire Short Form (IPAQ-SF)
Baseline, 4 weeks and 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Neal Millar, PhD FRCSEd, University of Glasgow
  • Study Director: Lorna Paul, MPhil PhD, Glasgow Caledonian University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2017

Primary Completion (Actual)

July 6, 2018

Study Completion (Actual)

July 6, 2018

Study Registration Dates

First Submitted

April 25, 2017

First Submitted That Met QC Criteria

May 8, 2017

First Posted (Actual)

May 9, 2017

Study Record Updates

Last Update Posted (Actual)

July 19, 2018

Last Update Submitted That Met QC Criteria

July 18, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • GN17PY175

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gluteal Tendinitis

Clinical Trials on Isometric exercise programme

Subscribe